AMARIN CORP PLC\UK Non Peo Neo Avg Total Comp Amt
AMARIN CORP PLC\UK (AMRN) reported Non Peo Neo Avg Total Comp Amt of $1.48 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-10.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-10
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $1.48M DEF 14A · filed 2026-04-10 |
| 2024-12-31 | $1.04M DEF 14A · filed 2026-04-10 |
| 2023-12-31 | $1.74M DEF 14A · filed 2026-04-10 |
| 2022-12-31 | $1.91M DEF 14A · filed 2026-04-10 |
| 2021-12-31 | $2.87M DEF 14A · filed 2026-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |